AtriCure (ATRC) Capital Expenditures (2010 - 2026)

AtriCure (ATRC) has 17 years of Capital Expenditures data on file, last reported at $3.9 million in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 76.62% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 1.33% decrease from a year earlier, with the FY2025 full-year figure at $9.0 million, down 21.02% from the prior year.
• Capital Expenditures for Q1 2026 stood at $3.9 million, up from $1.6 million in the prior quarter.
• Over the last five years, Capital Expenditures for ATRC reached as high as $6.6 million in Q3 2025 and fell as low as -$1.6 million in Q4 2022.
• Historically, Capital Expenditures has averaged $1.5 million across 5 years, with a median of $1.6 million in 2022.
• Across the five-year window, Capital Expenditures soared 1186.75% in 2024 and slumped 153.94% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at -$1.6 million in 2022, then surged by 143.34% to $713000.0 in 2023, then soared by 277.7% to $2.7 million in 2024, then tumbled by 40.51% to $1.6 million in 2025, then soared by 140.45% to $3.9 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $3.9 million in Q1 2026, $1.6 million in Q4 2025, and $6.6 million in Q3 2025.